Molecular Therapies Symposium

26 Jan Molecular Therapies Symposium

NCCN recently hosted a symposium on targeted therapy in paediatric oncology, featuring guest speaker Dr Katie Janeaway from Harvard Medical School and Boston Children’s Hospital, moderator Professor Geoff McCowage from Sydney Children’s Hospital Network at Westmead and local presenter Dr Andrew Wood, Paediatric Oncologist at Starship and Senior Research Fellow at the University of Auckland. The goal of the workshop was to seek broad national consensus on our philosophy and decision making process for molecular medicine as a precursor for a guideline document. The morning session is available by downloading the video links below.

Dr Andy Wood – Molecular Diagnostics and Therapy in Paediatric Oncology

Professor Geoff McCowage – Tumour Profiling and Drug Providing (Australia and Europe)

Dr Katherine Janeway – Harnessing genomics for Diagnosis and Treatment selection in the Pediatric Oncology Clinic: What have we learned

Dr Katherine Janeway – Harnessing genomics for Diagnosis and Treatment selection in the Pediatric Oncology Clinic: Clinical interpretation of Genomic Data

Dr Katherine Janeway – Harnessing Genomics for diagnosis and treatment selection in the pediatric oncology clinic:The road ahead

Dr Siobhan Cross – ANZCHOG guidelines for PH-Like Leukaemia Testing